Moderna to start final testing stage of coronavirus vaccine in July
June 11, 2020
Japan’s Takeda to sell some Asia-focused drugs to Celltrion for $278 million
June 11, 2020

Exclusive: Pershing Square’s Ackman eyes $1 billion-plus ‘blank-check’ company – sources

Billionaire investor William Ackman’s hedge fund Pershing Square Capital Management has filed confidentially with U.S. regulators for an initial public offering (IPO) of a blank-check investment vehicle that could raise more than $1 billion and be the biggest of its kind, according to people familiar with the matter.

Powered by WPeMatico